Security Snapshot

Savara Inc - Common Stock, par value $0.001 per share (SVRA) Institutional Ownership

CUSIP: 805111101

13F Institutional Holders and Ownership History from Q1 2016 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

148

Shares (Excl. Options)

201,186,328

Price

$6.03

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
SVRA on Nasdaq
Shares outstanding
210,922,101
Price per share
$5.46
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
201,186,328
Total reported value
$1,213,175,994
% of total 13F portfolios
0%
Share change
+36,178,165
Value change
+$226,717,931
Number of holders
148
Price from insider filings
$5.46
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • SVRA - Savara Inc - Common Stock, par value $0.001 per share is tracked under CUSIP 805111101.
  • 148 institutions reported positions in Q4 2025.
  • 11 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 148 to 6 between Q4 2025 and Q1 2026.
  • Reported value moved from $1,213,175,994 to $2,300,060.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 148 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 805111101?
CUSIP 805111101 identifies SVRA - Savara Inc - Common Stock, par value $0.001 per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Savara Inc - Common Stock, par value $0.001 per share (SVRA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Growth Equity Opportunities 17, LLC 12% $87,362,412 24,471,264 Growth Equity Opportunities 17, LLC 12 Nov 2025
Venrock Healthcare Capital Partners III, L.P. 9.9% +37% $123,617,225 +$48,545,450 20,881,288 +65% Venrock Healthcare Capital Partners III, L.P. 31 Dec 2025
Bain Capital Life Sciences Fund II, L.P. 10% $55,969,975 17,600,621 Bain Capital Life Sciences Fund II, L.P. 25 Mar 2025
Farallon Capital Partners, L.P. 6.9% -31% $90,445,500 -$19,831,599 15,000,000 -18% Dapice Joshua J. 31 Dec 2025
Flynn James E 6.7% $48,441,330 13,569,000 Deerfield Mgmt, L.P. 30 Oct 2025
TCG Crossover GP I, LLC 6.1% $73,184,254 12,362,205 TCG Crossover GP I, LLC 31 Dec 2025
BlackRock, Inc. 5.4% +12% $66,069,364 +$15,933,163 10,957,322 +32% BlackRock, Inc. 31 Dec 2025
Frazier Life Sciences Public Fund, L.P. 4.1% +5% $49,390,844 +$9,458,692 8,343,048 +24% Frazier Life Sciences Public Fund, L.P. 31 Dec 2025
Nantahala Capital Management, LLC 3.6% -29% $43,481,115 -$8,469,105 7,344,783 -16% Nantahala Capital Management, LLC 31 Dec 2025
WELLINGTON MANAGEMENT GROUP LLP 3.2% $17,431,660 5,481,654 Wellington Management Group LLP 31 Dec 2024
Vestal Point Capital, LP 2.3% -67% $14,333,550 -$24,133,200 4,015,000 -63% Vestal Point Capital, LP 30 Sep 2025

As of 31 Dec 2025, 148 institutional investors reported holding 201,186,328 shares of Savara Inc - Common Stock, par value $0.001 per share (SVRA). This represents 95% of the company’s total 210,922,101 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Savara Inc - Common Stock, par value $0.001 per share (SVRA) together control 84% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
NEA Management Company, LLC 12% 24,471,264 0% 7.5% $147,561,722
Bain Capital Life Sciences Investors, LLC 8.3% 17,600,621 0% 8.1% $106,131,745
VR ADVISER, LLC 6.5% 13,740,375 +8.4% 4.1% $82,854,461
DEERFIELD MANAGEMENT COMPANY, L.P. 6.4% 13,569,000 +70% 1% $81,821,070
TCG Crossover Management, LLC 5.9% 12,362,205 0% 2.5% $74,544,096
BlackRock, Inc. 5.3% 11,097,289 +31% 0% $66,916,652
VANGUARD GROUP INC 4.8% 10,041,647 +21% 0% $60,551,132
Frazier Life Sciences Management, L.P. 4.7% 9,862,301 -14% 1.6% $59,469,675
Polar Capital Holdings Plc 3.9% 8,306,196 0.23% $50,086,362
Nantahala Capital Management, LLC 3.5% 7,344,783 -16% 2.6% $44,289,041
RTW INVESTMENTS, LP 2.8% 5,952,380 0.36% $35,892,851
MARSHALL WACE, LLP 2.2% 4,559,921 0.03% $27,496,325
STATE STREET CORP 2.1% 4,333,022 +84% 0% $26,128,123
Woodline Partners LP 2% 4,244,640 +1689% 0.1% $25,595,179
EMERALD ADVISERS, LLC 1.7% 3,495,496 -0.96% 0.65% $21,077,841
GEODE CAPITAL MANAGEMENT, LLC 1.6% 3,417,769 +22% 0% $20,613,145
Rosalind Advisors, Inc. 1.6% 3,403,721 -15% 7.9% $20,524,438
Affinity Asset Advisors, LLC 1.3% 2,797,153 +86% 1.2% $16,866,833
WELLINGTON MANAGEMENT GROUP LLP 1.3% 2,674,931 +1.2% 0% $16,129,834
Spruce Street Capital LP 1.1% 2,411,093 0% 4.8% $14,538,891
PERCEPTIVE ADVISORS LLC 1.1% 2,400,000 0.27% $14,472,000
EMERALD MUTUAL FUND ADVISERS TRUST 1.1% 2,396,458 +11% 0.7% $14,450,642
MORGAN STANLEY 1.1% 2,337,896 +22% 0% $14,097,514
NAN FUNG TRINITY (HK) LTD 0.8% 1,688,500 0.81% $10,181,655
D. E. Shaw & Co., Inc. 0.79% 1,669,370 +349% 0.01% $10,066,301

Institutional Holders of Savara Inc - Common Stock, par value $0.001 per share (SVRA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 420,739 $2,300,060 +$1,749,956 $5.46 6
2025 Q4 201,186,328 $1,213,175,994 +$226,717,931 $6.03 148
2025 Q3 163,027,204 $581,865,188 -$17,744,664 $3.57 124
2025 Q2 167,625,869 $382,185,936 +$4,604,999 $2.28 121
2025 Q1 165,084,968 $457,300,361 +$4,913,528 $2.77 133
2024 Q4 162,865,251 $500,000,306 -$4,524,160 $3.07 134
2024 Q3 160,489,937 $680,419,874 +$47,632,176 $4.24 124
2024 Q2 148,167,816 $597,127,886 +$107,030,245 $4.03 130
2024 Q1 121,071,712 $602,921,495 +$11,975,850 $4.98 119
2023 Q4 118,973,088 $559,183,072 +$9,052,732 $4.70 97
2023 Q3 116,727,664 $441,241,214 +$105,054,525 $3.78 83
2023 Q2 89,090,177 $284,756,437 +$19,803,798 $3.20 76
2023 Q1 83,504,156 $162,832,384 +$6,962,703 $1.95 67
2022 Q4 79,984,853 $123,981,605 +$92,945 $1.55 52
2022 Q3 79,924,185 $123,886,636 +$4,248,900 $1.55 47
2022 Q2 77,190,826 $117,329,451 +$2,431,393 $1.52 47
2022 Q1 75,835,578 $99,344,996 +$1,530,761 $1.31 45
2021 Q4 74,670,485 $92,591,002 -$976,827 $1.24 45
2021 Q3 75,014,959 $103,530,069 -$1,889,497 $1.38 54
2021 Q2 76,209,813 $129,561,285 +$1,307,097 $1.70 69
2021 Q1 75,191,392 $156,437,847 +$111,831,290 $2.08 77
2020 Q4 21,657,964 $24,908,582 -$596,543 $1.15 61
2020 Q3 17,084,936 $18,623,392 -$4,005,800 $1.09 62
2020 Q2 19,585,868 $48,753,921 +$1,741,034 $2.49 68
2020 Q1 18,855,821 $39,855,026 +$5,880,157 $2.12 66
2019 Q4 20,751,617 $92,685,951 +$30,690,713 $4.48 73
2019 Q3 15,182,212 $40,233,563 -$4,106,411 $2.65 68
2019 Q2 16,990,991 $40,327,803 -$12,805,494 $2.37 73
2019 Q1 16,380,544 $120,724,460 -$5,355,801 $7.37 79
2018 Q4 17,105,808 $129,490,149 -$12,381,610 $7.57 74
2018 Q3 17,983,685 $200,696,346 +$36,314,360 $11.16 78
2018 Q2 14,712,320 $166,549,936 +$22,144,237 $11.32 73
2018 Q1 12,952,732 $119,160,226 +$8,218,669 $9.20 57
2017 Q4 11,673,132 $173,228,000 +$108,421,524 $14.84 47
2017 Q3 4,417,956 $41,504,000 +$5,010,883 $9.35 16
2017 Q2 3,979,135 $23,397,000 +$23,397,000 $5.88 16
2016 Q2 0 $0 -$1,000 $5.46 0
2016 Q1 142 $1,000 $7.04 1